Secondary hyperparathyroidism (SHPT) is common among patients with diabetic nephropathy (DN), a new study found.

Of 437 DN patients, 374 (85.6%) had intact parathyroid hormone (iPTH) levels above 65 pg/mL, Mahmoud Hamada Imam, MD, and colleagues of Benha University in Egypt, reported. Compared with patients who had normal iPTH, patients with SHPT displayed worse kidney function. Lab results showed a significantly lower urinary albumin to creatinine ratio (UACR, 2.38 vs 3.11 mg/g) and estimated glomerular filtration rate (eGFR, 49.15 vs 90.97 mL/min/1.73m2), as well as significantly higher serum urea (77.54 vs 23.70 mg/dL). The patients with SHPT also had lower levels of vitamin D and serum calcium. On further analyses, the team found strong associations between iPTH and serum creatinine, eGFR, UACR, and vitamin D levels.

Related Articles

Reference

Imam MH, Elshourbagy AW, Mohamady A, and Sarhan R. Prevalence of secondary hyperparathyroidism among patients with diabetic nephropathy. Presented at Kidney Week 2017 in New Orleans (Oct. 31-Nov. 5). Abstract FR-PO481.